229 related articles for article (PubMed ID: 30691683)
1. Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy.
Xiang L; Semenza GL
Adv Cancer Res; 2019; 141():175-212. PubMed ID: 30691683
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors.
Semenza GL
Clin Sci (Lond); 2015 Dec; 129(12):1037-45. PubMed ID: 26405042
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.
Zhang C; Zhi WI; Lu H; Samanta D; Chen I; Gabrielson E; Semenza GL
Oncotarget; 2016 Oct; 7(40):64527-64542. PubMed ID: 27590511
[TBL] [Abstract][Full Text] [Related]
4. HIF-1 recruits NANOG as a coactivator for TERT gene transcription in hypoxic breast cancer stem cells.
Lu H; Lyu Y; Tran L; Lan J; Xie Y; Yang Y; Murugan NL; Wang YJ; Semenza GL
Cell Rep; 2021 Sep; 36(13):109757. PubMed ID: 34592152
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells.
Shiraishi A; Tachi K; Essid N; Tsuboi I; Nagano M; Kato T; Yamashita T; Bando H; Hara H; Ohneda O
Cancer Sci; 2017 Mar; 108(3):362-372. PubMed ID: 28012234
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m⁶A-demethylation of NANOG mRNA.
Zhang C; Samanta D; Lu H; Bullen JW; Zhang H; Chen I; He X; Semenza GL
Proc Natl Acad Sci U S A; 2016 Apr; 113(14):E2047-56. PubMed ID: 27001847
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of Breast Cancer Stem Cell Specification and Self-Renewal Mediated by Hypoxia-Inducible Factor 1.
Semenza GL
Stem Cells Transl Med; 2023 Dec; 12(12):783-790. PubMed ID: 37768037
[TBL] [Abstract][Full Text] [Related]
8. The role of hypoxia-inducible factors in breast cancer stem cell specification.
Karami Fath M; Garousi S; Mottahedi M; Ghasemzadeh N; Salmani K; Olfati F; Beit Saeed M; Sotoudeh S; Barati G
Pathol Res Pract; 2023 Mar; 243():154349. PubMed ID: 36791562
[TBL] [Abstract][Full Text] [Related]
9. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
10. MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer.
Roscigno G; Puoti I; Giordano I; Donnarumma E; Russo V; Affinito A; Adamo A; Quintavalle C; Todaro M; Vivanco MD; Condorelli G
Oncotarget; 2017 Mar; 8(12):19507-19521. PubMed ID: 28061479
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-Induced Ca
Lu H; Chen I; Shimoda LA; Park Y; Zhang C; Tran L; Zhang H; Semenza GL
Cell Rep; 2017 Feb; 18(8):1946-1957. PubMed ID: 28228260
[TBL] [Abstract][Full Text] [Related]
12. Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia.
Peng F; Wang JH; Fan WJ; Meng YT; Li MM; Li TT; Cui B; Wang HF; Zhao Y; An F; Guo T; Liu XF; Zhang L; Lv L; Lv DK; Xu LZ; Xie JJ; Lin WX; Lam EW; Xu J; Liu Q
Oncogene; 2018 Feb; 37(8):1062-1074. PubMed ID: 29106390
[TBL] [Abstract][Full Text] [Related]
13. Plexin-B3 expression stimulates MET signaling, breast cancer stem cell specification, and lung metastasis.
Zuo Q; Yang Y; Lyu Y; Yang C; Chen C; Salman S; Huang TY; Wicks EE; Jackson W; Datan E; Qin W; Semenza GL
Cell Rep; 2023 Mar; 42(3):112164. PubMed ID: 36857181
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment.
Lan J; Lu H; Samanta D; Salman S; Lu Y; Semenza GL
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):E9640-E9648. PubMed ID: 30242135
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-induced S100A10 recruits KDM6A to facilitate OCT4-mediated breast cancer stemness.
Lu H; Xie Y; Tran L; Lan J; Yang Y; Murugan NL; Wang R; Wang YJ; Semenza GL
J Clin Invest; 2020 Sep; 130(9):4607-4623. PubMed ID: 32427586
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype.
Xiang L; Gilkes DM; Hu H; Takano N; Luo W; Lu H; Bullen JW; Samanta D; Liang H; Semenza GL
Oncotarget; 2014 Dec; 5(24):12509-27. PubMed ID: 25587023
[TBL] [Abstract][Full Text] [Related]
17. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment.
Lu H; Tran L; Park Y; Chen I; Lan J; Xie Y; Semenza GL
Cancer Res; 2018 Aug; 78(15):4191-4202. PubMed ID: 29880481
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia, stem cells and bone tumor.
Zeng W; Wan R; Zheng Y; Singh SR; Wei Y
Cancer Lett; 2011 Dec; 313(2):129-36. PubMed ID: 21999934
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype.
Lu H; Samanta D; Xiang L; Zhang H; Hu H; Chen I; Bullen JW; Semenza GL
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):E4600-9. PubMed ID: 26229077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]